共 24 条
[1]
Hiroaki H,Tuohy N A,Woo J T,et al.The Calcineurin/NFAT signaling patheway regulates osteoclastogenesis inRAW264.7 cells. Journal of Biological Chemistry . 2004
[2]
Analis E,Delany A M.Mechanisms of glucocorticoid action inbone. Annals of the New York Academy of Sciences . 2002
[3]
Khosla S.Minireview:the OPG/RANKL/RANK system. The Journal of Endocrinology . 2001
[4]
Hofbauer L C,Lacey D L,Dunstan C R,et al.Interleukin-1βand tumor necrosis factor-α,but not interleulkin-6 stimulateosteoprotegerin ligand gene expression in human osteoblasticcell. Bone . 1999
[5]
Helena B,Kenweth B J,Olle V,et al.Tumor necrosis factor-αandβup-regulate the levels of osteoprotegerin mRNA in hu-man osteosarcoma MG-63 cell. Biochemistry and Biophysics . 1998
[6]
Hsu H,Lacey D L,Dunstan C R,et al.Tumor necrosis fac-tor receptor family member RANK mediates osteoclast differ-entiation and activation induced by osteoprotegerin ligand. Proceedings of the National Academy of Sciences of the United States of America . 1999
[7]
Bone[P]. BIRL JOSEPH J.中国专利:US2436283A,1948-02-17
[8]
Olle N A V,Klara S,Bengt I E,et al.Osteoprotegerin mR-NA increased by interleukin-1αin human osteosarcoma cell lineMG-63 and in human osteoblast-like cells. Biochemical and Biophysical Research Communications . 1998
[9]
Sakata M,Shiba H,Komatsuzawa H,et al.Osteoprotegerinlevels increased by interleukin-1beta in human periodontal liga-ment cells are suppressed through prostaglandin E(2)synthe-sizedde novo. Cytokine . 2002
[10]
Helena B,Kenneth B J,Claes O,et al.Regulation of osteo-protegerin mRNA levels by prostaguandin E2in human bonemarrow stroma cells. Biochemical and Biophysical Research Communications . 1998